Report cover image

Global Non-Animal Softgel Capsules Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 103 Pages
SKU # APRC20353620

Description

Summary

According to APO Research, The global Non-Animal Softgel Capsules market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Non-Animal Softgel Capsules is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Non-Animal Softgel Capsules include Sirio, Erkang, Baihe, Aland, Sunsho Pharmaceutical, Robinson Pharma, Procaps Laboratorios, Fuji Capsule and EuroCaps, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Animal Softgel Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Animal Softgel Capsules.

The Non-Animal Softgel Capsules market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Animal Softgel Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Non-Animal Softgel Capsules Segment by Company

Sirio
Erkang
Baihe
Aland
Sunsho Pharmaceutical
Robinson Pharma
Procaps Laboratorios
Fuji Capsule
EuroCaps
Catalent
Captek
Bahrain Pharma
Aenova

Non-Animal Softgel Capsules Segment by Type

Starch Softgel
Gellan Gum Softgel
Carrageenan Softgel

Non-Animal Softgel Capsules Segment by Application

Health Supplements
Pharmaceutical
Others

Non-Animal Softgel Capsules Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Animal Softgel Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Non-Animal Softgel Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Animal Softgel Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Animal Softgel Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Non-Animal Softgel Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Table of Contents

103 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Non-Animal Softgel Capsules Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Non-Animal Softgel Capsules Sales Estimates and Forecasts (2020-2031)
1.3 Non-Animal Softgel Capsules Market by Type
1.3.1 Starch Softgel
1.3.2 Gellan Gum Softgel
1.3.3 Carrageenan Softgel
1.4 Global Non-Animal Softgel Capsules Market Size by Type
1.4.1 Global Non-Animal Softgel Capsules Market Size Overview by Type (2020-2031)
1.4.2 Global Non-Animal Softgel Capsules Historic Market Size Review by Type (2020-2025)
1.4.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
1.5.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
1.5.4 South America Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Non-Animal Softgel Capsules Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Non-Animal Softgel Capsules Industry Trends
2.2 Non-Animal Softgel Capsules Industry Drivers
2.3 Non-Animal Softgel Capsules Industry Opportunities and Challenges
2.4 Non-Animal Softgel Capsules Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Non-Animal Softgel Capsules Revenue (2020-2025)
3.2 Global Top Players by Non-Animal Softgel Capsules Sales (2020-2025)
3.3 Global Top Players by Non-Animal Softgel Capsules Price (2020-2025)
3.4 Global Non-Animal Softgel Capsules Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Non-Animal Softgel Capsules Major Company Production Sites & Headquarters
3.6 Global Non-Animal Softgel Capsules Company, Product Type & Application
3.7 Global Non-Animal Softgel Capsules Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Non-Animal Softgel Capsules Market CR5 and HHI
3.8.2 Global Top 5 and 10 Non-Animal Softgel Capsules Players Market Share by Revenue in 2024
3.8.3 2023 Non-Animal Softgel Capsules Tier 1, Tier 2, and Tier 3
4 Non-Animal Softgel Capsules Regional Status and Outlook
4.1 Global Non-Animal Softgel Capsules Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Non-Animal Softgel Capsules Historic Market Size by Region
4.2.1 Global Non-Animal Softgel Capsules Sales in Volume by Region (2020-2025)
4.2.2 Global Non-Animal Softgel Capsules Sales in Value by Region (2020-2025)
4.2.3 Global Non-Animal Softgel Capsules Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Region
4.3.1 Global Non-Animal Softgel Capsules Sales in Volume by Region (2026-2031)
4.3.2 Global Non-Animal Softgel Capsules Sales in Value by Region (2026-2031)
4.3.3 Global Non-Animal Softgel Capsules Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Non-Animal Softgel Capsules by Application
5.1 Non-Animal Softgel Capsules Market by Application
5.1.1 Health Supplements
5.1.2 Pharmaceutical
5.1.3 Others
5.2 Global Non-Animal Softgel Capsules Market Size by Application
5.2.1 Global Non-Animal Softgel Capsules Market Size Overview by Application (2020-2031)
5.2.2 Global Non-Animal Softgel Capsules Historic Market Size Review by Application (2020-2025)
5.2.3 Global Non-Animal Softgel Capsules Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
5.3.2 Europe Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
5.3.4 South America Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Non-Animal Softgel Capsules Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Sirio
6.1.1 Sirio Comapny Information
6.1.2 Sirio Business Overview
6.1.3 Sirio Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sirio Non-Animal Softgel Capsules Product Portfolio
6.1.5 Sirio Recent Developments
6.2 Erkang
6.2.1 Erkang Comapny Information
6.2.2 Erkang Business Overview
6.2.3 Erkang Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Erkang Non-Animal Softgel Capsules Product Portfolio
6.2.5 Erkang Recent Developments
6.3 Baihe
6.3.1 Baihe Comapny Information
6.3.2 Baihe Business Overview
6.3.3 Baihe Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Baihe Non-Animal Softgel Capsules Product Portfolio
6.3.5 Baihe Recent Developments
6.4 Aland
6.4.1 Aland Comapny Information
6.4.2 Aland Business Overview
6.4.3 Aland Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Aland Non-Animal Softgel Capsules Product Portfolio
6.4.5 Aland Recent Developments
6.5 Sunsho Pharmaceutical
6.5.1 Sunsho Pharmaceutical Comapny Information
6.5.2 Sunsho Pharmaceutical Business Overview
6.5.3 Sunsho Pharmaceutical Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sunsho Pharmaceutical Non-Animal Softgel Capsules Product Portfolio
6.5.5 Sunsho Pharmaceutical Recent Developments
6.6 Robinson Pharma
6.6.1 Robinson Pharma Comapny Information
6.6.2 Robinson Pharma Business Overview
6.6.3 Robinson Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Robinson Pharma Non-Animal Softgel Capsules Product Portfolio
6.6.5 Robinson Pharma Recent Developments
6.7 Procaps Laboratorios
6.7.1 Procaps Laboratorios Comapny Information
6.7.2 Procaps Laboratorios Business Overview
6.7.3 Procaps Laboratorios Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Procaps Laboratorios Non-Animal Softgel Capsules Product Portfolio
6.7.5 Procaps Laboratorios Recent Developments
6.8 Fuji Capsule
6.8.1 Fuji Capsule Comapny Information
6.8.2 Fuji Capsule Business Overview
6.8.3 Fuji Capsule Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Fuji Capsule Non-Animal Softgel Capsules Product Portfolio
6.8.5 Fuji Capsule Recent Developments
6.9 EuroCaps
6.9.1 EuroCaps Comapny Information
6.9.2 EuroCaps Business Overview
6.9.3 EuroCaps Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.9.4 EuroCaps Non-Animal Softgel Capsules Product Portfolio
6.9.5 EuroCaps Recent Developments
6.10 Catalent
6.10.1 Catalent Comapny Information
6.10.2 Catalent Business Overview
6.10.3 Catalent Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Catalent Non-Animal Softgel Capsules Product Portfolio
6.10.5 Catalent Recent Developments
6.11 Captek
6.11.1 Captek Comapny Information
6.11.2 Captek Business Overview
6.11.3 Captek Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Captek Non-Animal Softgel Capsules Product Portfolio
6.11.5 Captek Recent Developments
6.12 Bahrain Pharma
6.12.1 Bahrain Pharma Comapny Information
6.12.2 Bahrain Pharma Business Overview
6.12.3 Bahrain Pharma Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Bahrain Pharma Non-Animal Softgel Capsules Product Portfolio
6.12.5 Bahrain Pharma Recent Developments
6.13 Aenova
6.13.1 Aenova Comapny Information
6.13.2 Aenova Business Overview
6.13.3 Aenova Non-Animal Softgel Capsules Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Aenova Non-Animal Softgel Capsules Product Portfolio
6.13.5 Aenova Recent Developments
7 North America by Country
7.1 North America Non-Animal Softgel Capsules Sales by Country
7.1.1 North America Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Non-Animal Softgel Capsules Sales by Country (2020-2025)
7.1.3 North America Non-Animal Softgel Capsules Sales Forecast by Country (2026-2031)
7.2 North America Non-Animal Softgel Capsules Market Size by Country
7.2.1 North America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Non-Animal Softgel Capsules Market Size by Country (2020-2025)
7.2.3 North America Non-Animal Softgel Capsules Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Non-Animal Softgel Capsules Sales by Country
8.1.1 Europe Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Non-Animal Softgel Capsules Sales by Country (2020-2025)
8.1.3 Europe Non-Animal Softgel Capsules Sales Forecast by Country (2026-2031)
8.2 Europe Non-Animal Softgel Capsules Market Size by Country
8.2.1 Europe Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Non-Animal Softgel Capsules Market Size by Country (2020-2025)
8.2.3 Europe Non-Animal Softgel Capsules Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Non-Animal Softgel Capsules Sales by Country
9.1.1 Asia-Pacific Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Non-Animal Softgel Capsules Sales by Country (2020-2025)
9.1.3 Asia-Pacific Non-Animal Softgel Capsules Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Non-Animal Softgel Capsules Market Size by Country
9.2.1 Asia-Pacific Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Non-Animal Softgel Capsules Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Non-Animal Softgel Capsules Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Non-Animal Softgel Capsules Sales by Country
10.1.1 South America Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Non-Animal Softgel Capsules Sales by Country (2020-2025)
10.1.3 South America Non-Animal Softgel Capsules Sales Forecast by Country (2026-2031)
10.2 South America Non-Animal Softgel Capsules Market Size by Country
10.2.1 South America Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Non-Animal Softgel Capsules Market Size by Country (2020-2025)
10.2.3 South America Non-Animal Softgel Capsules Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Non-Animal Softgel Capsules Sales by Country
11.1.1 Middle East and Africa Non-Animal Softgel Capsules Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Non-Animal Softgel Capsules Sales by Country (2020-2025)
11.1.3 Middle East and Africa Non-Animal Softgel Capsules Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country
11.2.1 Middle East and Africa Non-Animal Softgel Capsules Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Non-Animal Softgel Capsules Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Non-Animal Softgel Capsules Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Non-Animal Softgel Capsules Value Chain Analysis
12.1.1 Non-Animal Softgel Capsules Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Non-Animal Softgel Capsules Production Mode & Process
12.2 Non-Animal Softgel Capsules Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Non-Animal Softgel Capsules Distributors
12.2.3 Non-Animal Softgel Capsules Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.